CVS Health Co. (NYSE:CVS) Shares Sold by Radnor Capital Management LLC

Radnor Capital Management LLC decreased its position in CVS Health Co. (NYSE:CVS) by 24.1% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 39,335 shares of the pharmacy operator’s stock after selling 12,479 shares during the period. Radnor Capital Management LLC’s holdings in CVS Health were worth $1,766,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Thurston Springer Miller Herd & Titak Inc. grew its position in CVS Health by 16.6% in the fourth quarter. Thurston Springer Miller Herd & Titak Inc. now owns 9,101 shares of the pharmacy operator’s stock worth $409,000 after acquiring an additional 1,296 shares during the period. Park Avenue Securities LLC grew its holdings in shares of CVS Health by 5.8% during the 4th quarter. Park Avenue Securities LLC now owns 24,646 shares of the pharmacy operator’s stock worth $1,106,000 after purchasing an additional 1,359 shares during the period. Oak Thistle LLC purchased a new stake in CVS Health in the 4th quarter valued at about $837,000. Mendota Financial Group LLC lifted its position in CVS Health by 32,600.0% in the fourth quarter. Mendota Financial Group LLC now owns 981 shares of the pharmacy operator’s stock valued at $44,000 after buying an additional 978 shares during the last quarter. Finally, Grandview Asset Management LLC acquired a new stake in shares of CVS Health during the fourth quarter valued at about $311,000. Institutional investors and hedge funds own 80.66% of the company’s stock.

CVS Health Trading Up 0.2 %

NYSE:CVS opened at $51.60 on Wednesday. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.59 and a current ratio of 0.80. CVS Health Co. has a 1 year low of $43.56 and a 1 year high of $80.75. The stock has a market cap of $64.93 billion, a P/E ratio of 13.10, a P/E/G ratio of 0.85 and a beta of 0.59. The stock has a 50-day simple moving average of $51.68 and a 200-day simple moving average of $56.44.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, beating the consensus estimate of $1.08 by $0.01. The company had revenue of $95.43 billion for the quarter, compared to analyst estimates of $92.72 billion. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The firm’s revenue was up 6.3% on a year-over-year basis. During the same period in the prior year, the firm posted $2.21 earnings per share. As a group, analysts anticipate that CVS Health Co. will post 5.32 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd will be issued a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 5.16%. The ex-dividend date is Thursday, January 23rd. CVS Health’s payout ratio is 67.51%.

Analysts Set New Price Targets

Several equities analysts have recently commented on the stock. Mizuho decreased their price objective on shares of CVS Health from $73.00 to $66.00 and set an “outperform” rating on the stock in a report on Thursday, October 24th. Evercore ISI lifted their price objective on CVS Health from $62.00 to $75.00 and gave the company an “outperform” rating in a research note on Tuesday, October 8th. UBS Group increased their target price on CVS Health from $60.00 to $62.00 and gave the stock a “neutral” rating in a research note on Thursday, November 7th. Royal Bank of Canada dropped their target price on CVS Health from $68.00 to $58.00 and set an “outperform” rating for the company in a research report on Friday, November 15th. Finally, TD Cowen raised their price objective on shares of CVS Health from $73.00 to $80.00 and gave the company a “buy” rating in a research note on Monday, November 25th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and thirteen have given a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $68.71.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.